Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101
Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference
Editas Medicine Announces Exclusive License to Advanced CRISPR Genome Editing Technology from Massachusetts General Hospital
Blackrock Silver Drills 5.03 Metres of 750 g/t AgEq and Reports Multiple Thick Mineralized Zones in First Assays from Eastern Expansion Drill Program at Tonopah West
